First vaccines for healthcare professionals and hospital patients. AstraZeneca and Pfizer-BioNTech vaccines are ready for use. Asia lags behind the US and Great Britain. In 2020, South Korean GDP was the third highest among advanced economies.
Seoul (AsiaNews / Agencies) - The national vaccination campaign against Covid-19 will begin over the weekend. South Korean health authorities announced yesterday, specifying that it will not be possible to obtain herd immunity by November. Previously, the government said it could vaccinate 70% of the population by September.
According to various observers, in addition to the delays in starting the inoculations, the problem is the distrust of the population towards vaccines. According to a recent survey, less than half of South Koreans are willing to get vaccinated right away.
On February 25, the first vaccines of the British-Swedish company AstraZeneca will be injected. The first to be vaccinated will be healthcare workers and hospital patients (under the age of 65). The following day, immunization with Pfizer-BioNTech's drug will begin.
Seoul begins vaccinations later than many other countries. In Great Britain, nearly 27 million single doses have been administered; in the US more than 19 million. In Asia, the Chinese stopped at 2.8 million; Japan and Australia have not yet started the campaign.
With just over 87,000 cases of contagion and 1,573 deaths, South Korea is among the countries that have managed the health emergency best. This has allowed the local economy to withstand the global crisis.
Data from the Organization for Economic Co-operation and Development reveal that Seoul's gross domestic product was the third best among advanced economies in 2020. South Korean GDP contracted by 1%, against a growth of the Chinese one of 2.3% and a contraction of the Norwegian one of 0.8%. Taiwan has outdone all other developed countries by far, recording a growth of 2.98%: the first overtaking against Beijing in 30 years.